<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0F9EAEAD-5674-4E30-8A06-589629F2C422"><gtr:id>0F9EAEAD-5674-4E30-8A06-589629F2C422</gtr:id><gtr:name>Haukeland University Hospital</gtr:name><gtr:address><gtr:line1>Haukeland University Hospital</gtr:line1><gtr:line2>Jonas Liesvei 65</gtr:line2><gtr:postCode>N-5021</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Human Genetics</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0F9EAEAD-5674-4E30-8A06-589629F2C422"><gtr:id>0F9EAEAD-5674-4E30-8A06-589629F2C422</gtr:id><gtr:name>Haukeland University Hospital</gtr:name><gtr:address><gtr:line1>Haukeland University Hospital</gtr:line1><gtr:line2>Jonas Liesvei 65</gtr:line2><gtr:postCode>N-5021</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/135BF251-9D97-4560-9F39-9C989A5E1A37"><gtr:id>135BF251-9D97-4560-9F39-9C989A5E1A37</gtr:id><gtr:firstName>Anna</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Mitchell</gtr:surname><gtr:orcidId>0000-0002-9946-183X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900390"><gtr:id>D2D10737-7F35-4CF4-978D-662B09FD448F</gtr:id><gtr:title>Genomic analyses of familial autoimmune Addison's disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0900390</gtr:grantReference><gtr:abstractText>Autoimmune Addison?s disease (AAD) is a rare condition in which the immune system attacks the adrenal glands which normally produce essential steroid hormones. People with AAD are dependent lifelong on taking daily steroid medication for survival. 

Like AAD, type I diabetes is an autoimmune disorder and results from an immune attack targeted, in part, against insulin in pancreatic cells. We know that variations in the insulin gene contribute to susceptibility to type I diabetes. In AAD, the target of the immune attack is an adrenal enzyme called 21-hydroxylase. Our hypothesis is that variations around the 21-hydroxylase gene might predispose an individual to AAD. 

We already know that a complex series of variations exist around the 21-hydroxylase gene. The first part of my project is to see if these variations contribute towards AAD susceptibility. For the second part of my study, I will use gene-chips containing more than a million DNA markers scattered regularly across all the chromosomes to look for markers that are transmitted with Addison?s disease in 25 families with 2 or 3 members affected by the condition. These studies should enhance our understanding of why AAD is so strongly inherited and will shed light on the mechanisms behind the disease.</gtr:abstractText><gtr:technicalSummary>Autoimmune Addison?s disease (AAD) is amongst the rarest of the autoimmune diseases and has a high genetic load, with a lambda-sib of more than 150. However little of the genetic susceptibility has so far been accounted for, suggesting that there may be one, or a small number, of aetiological variants exerting very strong effects. Investigating AAD is important, as more than half of patients will develop a second autoimmune condition, suggesting that the alleles responsible for AAD will also contribute to susceptibility to other autoimmune conditions e.g. type I diabetes.

The major autoantigen for AAD is the steroidogenic enzyme, 21-hydroxylase. Variations at the insulin gene and thyrotropin receptor gene predispose to type 1 diabetes and Graves? disease, respectively. Therefore, it is plausible that variations in or around the gene encoding 21-hydroxylase will predispose to AAD. The 21-hydroxylase gene (CYP21B) is located in the MHC class III region, adjacent to the complement factor 4 gene, both contained within a known copy number variation. CYP21B is close to its own pseudogene, which also exists in several copy number states. In the first part of my study, I will use PCR-based approaches to determine whether structural variations at the CYP21 locus predispose to AAD, including quantitative real-time PCR, long range PCR and paralogue ratio testing. To pursue these studies, a unique sample resource is available to me, comprising 25 multiplex AAD families, 320 unrelated UK AAD probands and matching healthy controls. 

In the second part of my project, I plan to perform a genome-wide linkage and association study, using SNP-chips containing 900,000 markers in members of the 25 UK and German kindreds with more than one affected AAD individual. I will analyse the data under the expert direction of genetic statistician Prof. Cordell, looking for the strength of the linkage signal and evidence for conserved haplotypes across different families. I will then takrward a series of the 200 most linked and associated markers to a replication experiment using a case-control design in the 320 unrelated AAD probands and 450 controls. This series of experiments should yield an unbiased insight into the genetic architecture of AAD for the first time. 

This project provides a scientific opportunity to gain a greater understanding of autoimmune disease pathogenesis, and offers a medical opportunity since AAD has fatal consequences if the diagnosis is missed. A high penetrance AAD allele that predicts disease would be valuable in screening at risk individuals, such as children with type 1 diabetes.</gtr:technicalSummary><gtr:fund><gtr:end>2013-04-06</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-07</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>189038</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC/Wellcome Trust Human Developmental Biology Resource</gtr:department><gtr:description>Expression of CYP21A2 and CYP21A1P in tissues</gtr:description><gtr:id>CDA6FE34-E2A6-448B-9635-B369DCD5E844</gtr:id><gtr:impact>Ongoing studies - future publication envisaged</gtr:impact><gtr:outcomeId>p17Eaaaij3G-1</gtr:outcomeId><gtr:partnerContribution>Tissue provided by Newcastle and Birmingham HDBRs</gtr:partnerContribution><gtr:piContribution>Studies of the expression of CYP21A2 and CYP21A1P in human tissues. Collaboration with the Newcastle HBDR and Birmingham HBRC for collection of human thymus and adrenal tissue. All studies (tissue in situ hybridisation, northern blotting, quantitative PCR, Western blotting) conceived and planned by myself and Prof Pearce. All analyses performed by me.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Haukeland University Hospital</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Endocrine Genetics Group</gtr:department><gtr:description>Collaboration with molecular genetics group in Bergen Norway</gtr:description><gtr:id>4E8C4AF5-9291-4BD7-9C7B-AC4B598762E7</gtr:id><gtr:impact>1 manuscript under review at present - PlosONE. Collaboration comprises scientists, technicians and clinicians</gtr:impact><gtr:outcomeId>Y2WA7Eeh8hc-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators identified, characterised and gathered DNA from Norwegian families.</gtr:partnerContribution><gtr:piContribution>Collaboration to gather samples from families with autoimmune Addison's disease for a linkage study. We identified, characterised and gathered DNA from UK families. All genotying was carried out in the UK. The data was analysed by myself, with Prof Cordell</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Thyroid Association Travel Grant</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>British Thyroid Association (BTA)</gtr:fundingOrg><gtr:id>56132F6F-885C-423E-BEE9-BA457549B17F</gtr:id><gtr:outcomeId>m6BcZxPCy2y0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Simon Wolff Charitable Foundation Travel Grant</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>The Simon Wolff Charitable Foundation</gtr:fundingOrg><gtr:id>DDA9E4E6-292D-495F-A04D-97BFFCF8B1EA</gtr:id><gtr:outcomeId>PWmRchKQ5Zg0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Society for Endocrinology Travel Grant</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Society for Endocrinology</gtr:fundingOrg><gtr:id>99E923A1-2700-42B1-94A8-2099129AC5C9</gtr:id><gtr:outcomeId>5460f33f259535.87322402</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Society for Endocrinology International Travel grant</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Society for Endocrinology</gtr:fundingOrg><gtr:id>95B50A9D-4239-4EF8-B32C-E38B15441247</gtr:id><gtr:outcomeId>TkG9LnR5hYv0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BFB47526-6E4D-41BD-95B0-F08C1C1ECB58</gtr:id><gtr:title>High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c504c639c42d25b9e7c11205a9dbeedd"><gtr:id>c504c639c42d25b9e7c11205a9dbeedd</gtr:id><gtr:otherNames>Dawoodji A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5460ed3c5b71e5.48837380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF9E39AB-8C79-4450-A64D-02AD131BB109</gtr:id><gtr:title>The role of functionally defective rare germline variants of sialic acid acetylesterase in autoimmune Addison's disease.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/035d0e4c4756ccd97aba54ac23cbeebc"><gtr:id>035d0e4c4756ccd97aba54ac23cbeebc</gtr:id><gtr:otherNames>Gan EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>pm_13393_23_23011869</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7784AE3A-41BC-4F40-A360-EC9F133AAF83</gtr:id><gtr:title>CTLA-4 as a genetic determinant in autoimmune Addison's disease.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d8f9b1266e842b448d31a804555e684"><gtr:id>9d8f9b1266e842b448d31a804555e684</gtr:id><gtr:otherNames>Wolff AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>5675e93ef100b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6D236B3-689C-44DC-B721-0592FCBC2A4E</gtr:id><gtr:title>Spontaneous and tetracosactide-induced anti-ACTH antibodies in man.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/035d0e4c4756ccd97aba54ac23cbeebc"><gtr:id>035d0e4c4756ccd97aba54ac23cbeebc</gtr:id><gtr:otherNames>Gan EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>56dd71ed9446b7.70309322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36195848-0FF0-44C8-98FF-20C7E94FB5C0</gtr:id><gtr:title>Role of the X-linked gene GPR174 in autoimmune Addison's disease.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a638e19d45cc5ab3047e7a8e39f2e9c4"><gtr:id>a638e19d45cc5ab3047e7a8e39f2e9c4</gtr:id><gtr:otherNames>Napier C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5460ec4d25b6c4.85943837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B495CAE-6B6F-4910-99E3-AA8EFB11AA1E</gtr:id><gtr:title>Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40d4aefc449834f9c0aba834ea778607"><gtr:id>40d4aefc449834f9c0aba834ea778607</gtr:id><gtr:otherNames>Mitchell AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675e5db0fb57</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0707957F-9594-47CC-8B24-6A17603212AC</gtr:id><gtr:title>Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's disease.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f78ce76102cae0546d0d6557520cfc67"><gtr:id>f78ce76102cae0546d0d6557520cfc67</gtr:id><gtr:otherNames>Pearce SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_13393_23_22767640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBDB62D1-37E2-42CB-A52B-BDD372C7BE07</gtr:id><gtr:title>Autoimmune Addison disease: pathophysiology and genetic complexity.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40d4aefc449834f9c0aba834ea778607"><gtr:id>40d4aefc449834f9c0aba834ea778607</gtr:id><gtr:otherNames>Mitchell AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-5029</gtr:issn><gtr:outcomeId>pm_13393_23_22290360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D01E0BAD-1B74-42B2-B73F-5FE9B17C7D47</gtr:id><gtr:title>Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40d4aefc449834f9c0aba834ea778607"><gtr:id>40d4aefc449834f9c0aba834ea778607</gtr:id><gtr:otherNames>Mitchell AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>pm_13393_23_21511493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B691BC86-5A2C-4BC3-9BB7-47A41AA04E1B</gtr:id><gtr:title>The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory Graves' orbitopathy.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40d4aefc449834f9c0aba834ea778607"><gtr:id>40d4aefc449834f9c0aba834ea778607</gtr:id><gtr:otherNames>Mitchell AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>pm_13393_23_23320840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB5266D8-E25C-42A7-8E93-2F238819060B</gtr:id><gtr:title>Genomic analyses of familial and sporadic autoimmune Addison's disease</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5caf3ff263f3ed8683f092a56d12ba79"><gtr:id>5caf3ff263f3ed8683f092a56d12ba79</gtr:id><gtr:otherNames>Mitchell Anna Louise</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>5460f68e4f58b6.95036946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A1E6828-696B-4974-A714-9DAC4C056064</gtr:id><gtr:title>The role of a nonsynonymous CD226 (DNAX-accessory molecule-1) variant (Gly 307Ser) in isolated Addison's disease and autoimmune polyendocrinopathy type 2 pathogenesis.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/035d0e4c4756ccd97aba54ac23cbeebc"><gtr:id>035d0e4c4756ccd97aba54ac23cbeebc</gtr:id><gtr:otherNames>Gan EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>pm_13393_23_21521299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E506961C-1BAB-4392-8E01-9B5E12D2941C</gtr:id><gtr:title>Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40d4aefc449834f9c0aba834ea778607"><gtr:id>40d4aefc449834f9c0aba834ea778607</gtr:id><gtr:otherNames>Mitchell AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5460ef0b064022.14193031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E9A06D0-5F78-4CC4-AD4D-2766353CFAE9</gtr:id><gtr:title>Respiratory chain complex I deficiency caused by mitochondrial DNA mutations.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13308921a9c6ca555cf90db4e0652d17"><gtr:id>13308921a9c6ca555cf90db4e0652d17</gtr:id><gtr:otherNames>Swalwell H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>pm_13393_23_21364701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>139FF707-760D-4F03-AB44-EBE12D713208</gtr:id><gtr:title>Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatment.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/035d0e4c4756ccd97aba54ac23cbeebc"><gtr:id>035d0e4c4756ccd97aba54ac23cbeebc</gtr:id><gtr:otherNames>Gan EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5460efb413eb13.80073045</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900390</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>